Cc1nn(-c2ccccn2)c2c1C(c1c(F)cccc1Cl)C1=C(O)c3ccccc3C1=N2
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?